Evidence map›Paper›PMID 41296602›Full record

ArticleJournal of clinical microbiology2025

Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study.

Niklas Wiesmann, Dominic Enders, Antje Westendorf, Raphael Koch, Frieder Schaumburg

Erratum issuedAbstract readValidation Study
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Rapid prediction of vancomycin-resistantFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Niklas Wiesmann *Institute of Medical Microbiology, University of Münster, Münster, Germany.ORCID 0009-0007-7238-2852
Dominic Enders *Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.ORCID 0000-0002-7815-7839
Antje WestendorfInstitute of Medical Informatics, University of Münster, Münster, Germany.ORCID 0009-0002-8019-4564
Raphael Koch *Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.ORCID 0000-0002-5581-5122
Frieder Schaumburg *Institute of Medical Microbiology, University of Münster, Münster, Germany.ORCID 0000-0002-9168-9290

Funding

Deutsche Forschungsgemeinschaft 544920804
6 · The paper itself

Abstract

Matrix-assisted laser desorption-ionization-time of flight (MALDI-TOF) mass spectra can be used to predict antimicrobial resistance (AMR) using machine learning (ML). This study aimed to validate the performance of ML models for AMR prediction using own and publicly available MALDI-TOF data and to test how these models perform over time. Mass spectra of IMPORTANCE: MALDI-TOF mass spectrometry can be used not only for bacterial species identification but also for the prediction of antimicrobial resistance (AMR) using machine learning (ML). Such an approach would provide antimicrobial susceptibility test results one day earlier than conventional routine diagnostics. This is essential for an early targeted treatment to reduce mortality of severe infections. We show that the performance of ML for the prediction of AMR based on MALDI-TOF data is good (AUROC ≥ 0.8). However, the ML models need to be trained on local data and retrained regularly to maintain a good performance.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialMachine LearningSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationEscherichia coliGermanyHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsROC CurveStaphylococcus aureusAnti-Bacterial Agentsanti-bacterial agentsartificial intelligencedrug resistancemachine learningmassmatrix-assisted laser desorption-ionizationmicrobialspectrometry

Identifiers

PMID41296602
PMCPMC12710331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.